Cognitive-behavioral Treatment of Anxiety/ Primary Care

焦虑的认知行为治疗/初级保健

基本信息

  • 批准号:
    7090602
  • 负责人:
  • 金额:
    $ 17.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-25 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by candidate): This Mentored Patient-Oriented Research Career Development Award (K23) will enable Dr. Weisberg to begin a programmatic line of research in the development and evaluation of intervention programs for medical patients with anxiety disorders. Her emphasis will be on developing a cognitive behavioral group treatment for primary care patients with anxiety disorders. Anxiety disorders are highly prevalent and impairing. Individuals seeking help for anxiety are more likely to be seen in primary care than in mental health settings, and the majority of these patients do not receive adequate treatment. Dr. Weisberg's training goals include: (1) broadening her knowledge and experience in treatment development, with a focus on developing and evaluating treatments for anxiety disorders in medical settings; (2) acquiring expertise in conducting interventions in primary care settings; (3) expanding her understanding of the conduct of treatment outcome studies; and (4) further developing her statistical skills, with particular emphasis on techniques relevant to intervention / clinical trials research. These training goals will be achieved through (1) the resources available at Brown Medical School; (2) the high quality mentorship provided by Drs. Martin Keller, Michelle Craske, Kay Dickersin, and the expertise of the assembled consultant team (Drs. David Barlow, Charles Eaton, and Robert Stout); (3) focused coursework, training, and clinical experiences; and (4) the proposed research project. The proposed research plan involves developing and empirically testing a new treatment for primary care patients with panic disorder, generalized anxiety disorder, and/or social anxiety disorder. The new treatment, Learning to Ease Anxiety in Primary care (LEAP) will incorporate methods universal to CBT for specific anxiety disorders (i.e., cognitive restructuring and exposure) and adapted for primary care patients with a range of anxiety diagnoses. The specific research aims are to: (1) develop the LEAP treatment, its manual, therapist training procedures, and treatment fidelity measures and (2) conduct a randomized, controlled pilot study comparing LEAP to treatment as usual, in order to evaluate the feasibility and acceptability of the proposed treatment, and obtain a treatment effect size to support an examination of the protocol in a future, larger trial.
描述(由候选人提供):这项以患者为导向的指导研究职业发展奖(K23)将使Weisberg博士能够开始对患有焦虑症的医疗患者的干预方案的开发和评估进行规划性的研究。她的重点将是开发一种认知行为群体治疗焦虑症的初级保健患者。焦虑症是非常普遍和有害的。因焦虑而寻求帮助的人更有可能在初级保健机构就诊,而不是在精神卫生机构,这些患者中的大多数没有得到充分的治疗。Weisberg博士的培训目标包括:(1)拓宽她在治疗开发方面的知识和经验,重点是在医疗环境中开发和评估焦虑症的治疗方法;(2)获得在初级保健机构进行干预的专业知识;(3)拓展她对治疗结果研究的理解;(4)进一步发展她的统计技能,特别强调与干预/临床试验研究相关的技术。这些培训目标将通过(1)布朗医学院的资源来实现;(2)博士的高质量指导。Martin Keller, Michelle Craske, Kay Dickersin,以及集结的顾问团队的专业知识(dr。大卫·巴洛、查尔斯·伊顿和罗伯特·斯托特);(3)有针对性的课程、培训和临床经验;(4)拟研究课题。拟议的研究计划包括开发和实证测试一种新的治疗惊恐障碍、广泛性焦虑障碍和/或社交焦虑障碍的初级保健患者的方法。新的治疗方法,学习缓解初级保健中的焦虑(LEAP)将结合CBT对特定焦虑症(即认知重构和暴露)的通用方法,并适用于具有一系列焦虑诊断的初级保健患者。具体的研究目标是:(1)制定LEAP治疗、其手册、治疗师培训程序和治疗保真度措施;(2)进行一项随机、对照的试点研究,将LEAP与常规治疗进行比较,以评估拟议治疗的可行性和可接受性,并获得治疗效应大小,以支持在未来更大规模的试验中对该方案的审查。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RISA B WEISBERG其他文献

RISA B WEISBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RISA B WEISBERG', 18)}}的其他基金

Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
  • 批准号:
    10255561
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
  • 批准号:
    10676262
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
  • 批准号:
    10624991
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Cognitive-behavioral Treatment of Anxiety/ Primary Care
焦虑的认知行为治疗/初级保健
  • 批准号:
    6926064
  • 财政年份:
    2004
  • 资助金额:
    $ 17.76万
  • 项目类别:
Cognitive-behavioral Treatment of Anxiety/ Primary Care
焦虑的认知行为治疗/初级保健
  • 批准号:
    7447384
  • 财政年份:
    2004
  • 资助金额:
    $ 17.76万
  • 项目类别:
Cognitive-behavioral Treatment of Anxiety/ Primary Care
焦虑的认知行为治疗/初级保健
  • 批准号:
    7265164
  • 财政年份:
    2004
  • 资助金额:
    $ 17.76万
  • 项目类别:
Cognitive-behavioral Treatment of Anxiety/ Primary Care
焦虑的认知行为治疗/初级保健
  • 批准号:
    6820173
  • 财政年份:
    2004
  • 资助金额:
    $ 17.76万
  • 项目类别:

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 17.76万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 17.76万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 17.76万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 17.76万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 17.76万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了